Humacyte Stock Forecast

Sell candidate since Jun 12, 2026 Loss -33.61%

The Humacyte, Inc. stock price fell by -16.55% on the last day (Tuesday, 23rd Jun 2026) from $0.84 to $0.700. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 23.67% from a day low at $0.695 to a day high of $0.86. The price has fallen in 8 of the last 10 days and is down by -49.25% for this period. Volume has increased on the last day by 22 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 46 million shares were bought and sold for approximately $31.92 million.

Given the current short-term trend, the stock is expected to rise 64.77% during the next 3 months and, with a 90% probability hold a price between $1.15 and $2.66 at the end of this 3-month period.

HUMA Signals & Forecast

There are few to no technical positive signals at the moment. The Humacyte, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.94 and $1.10. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -52.99%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Humacyte, Inc. stock

Humacyte, Inc. finds support from accumulated volume at $0.676 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.165 between high and low, or 23.67%. For the last week, the stock has had daily average volatility of 13.31%.

Humacyte, Inc. is oversold on RSI14 (16). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HUMA) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Humacyte, Inc. to open at $0.752, and during the day (based on 14 day Average True Range), to move between $0.638 and $0.763, which gives a possible trading interval of +/-$0.125 (+/-19.68%) up or down from last closing price. If Humacyte, Inc. takes out the full calculated possible swing range there will be an estimated 19.68% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.676 (3.54%) than the resistance at $0.794 (13.42%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Humacyte, Inc. stock A Buy?

The Humacyte, Inc. stock holds several negative signals and despite the positive trend, we believe Humacyte, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.219 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $0.752 ( 7.36%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk